F-star Therapeutics, Inc. 3 SEC Filings

Filed On	Filing
24 Nov 2020	Form 3: Race Geoffrey, Director No securities owned
24 Nov 2020	Form 3: Krol Patrick Johan Hendrik, Director No securities owned
24 Nov 2020	Form 3: Kayitalire Louis, Chief Medical Officer No securities owned
24 Nov 2020	Form 3: Forster Eliot, Director No securities owned
24 Nov 2020	Form 3: Deptula-hicks Darlene M, Treasurer and CFO No securities owned
24 Nov 2020	Form 3: Brewis Neil, Chief Scientific Officer No securities owned
24 Nov 2020	Form 3: Bermingham Nessan, Director No securities owned
24 Nov 2020	Form 3: Benz Edward Jr, Director No securities owned
24 Apr 2020	Form 3: Firmani Lori, VP of Finance and Treasurer Holds 7,169 shares of Common Stock
09 Mar 2020	Form 3: Winslow Garrett, General Counsel and Secretary
11 Jul 2019	Form 3: Klein Pamela M., Director Holds 0 shares of No securities are beneficially owned.
17 Aug 2018	Form 3: Smith Scott Andrew, Director Holds 0 shares of No securities are beneficially owned
05 Mar 2018	Form 3: Clackson Timothy P, Director Holds 0 shares of No securities are beneficially owned
06 Feb 2018	Form 3: Mpm Oncology Impact Management Gp Llc, 10% owner and 3 others Holds 833,839 shares of Common Stock
30 Oct 2017	Form 3: Bardon Christiana, Director Holds 833,839 shares of Common Stock
29 Jul 2016	Form 3: Brady Todd C, Director Holds 0 shares of No securities are beneficially owned
05 May 2016	Form 3: Afdhal Nezam H., Chief Medical Officer Holds 31,250 shares of Common Stock
05 May 2016	Form 3: Iyer Radhakrishnan P., Director Holds 431,250 shares of Common Stock
05 May 2016	Form 3: Driscoll Martin J, Director
05 May 2016	Form 3: Eichler Kurt M, Director Holds 382.324 shares of Common Stock

Comments